Shenzhen New Industries Biomedical Engineering Co., Ltd. (SHE:300832)
China
· Delayed Price · Currency is CNY 58.19
-0.01 (-0.02%)
Mar 28, 2025, 2:44 PM CST
SHE:300832 Market Cap
SHE:300832 has a market cap or net worth of 45.66 billion as of March 28, 2025. Its market cap has decreased by -28.25% in one year.
Market Cap
45.66B
Enterprise Value
43.08B
Revenue
4.44B
Ranking
n/a
PE Ratio
24.67
Stock Price
58.19
Market Cap Chart
Since May 12, 2020, SHE:300832's market cap has increased from 18.60B to 45.66B, an increase of 145.42%. That is a compound annual growth rate of 20.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 45.66B | -17.98% |
| Dec 31, 2024 | 55.67B | -9.40% |
| Dec 29, 2023 | 61.44B | 55.88% |
| Dec 30, 2022 | 39.42B | 13.75% |
| Dec 31, 2021 | 34.65B | -36.37% |
| Dec 31, 2020 | 54.45B | 192.70% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 309.09B |
| Shenzhen Mindray Bio-Medical Electronics | 287.93B |
| WuXi AppTec | 194.66B |
| Aier Eye Hospital Group | 125.42B |
| Zhangzhou Pientzehuang Pharmaceutical., | 122.96B |
| Yunnan Baiyao Group Co.,Ltd | 100.54B |
| Shanghai United Imaging Healthcare | 100.16B |
| Sichuan Biokin Pharmaceutical | 95.03B |